SeaSpine Holdings (NSDQ:SPNE) posted fourth-quarter results that missed the consensus forecast on Wall Street. The Carlsbad, Calif.-based company reported losses of $10.3 million, or -37¢ per share, on sales of $46.4 million for the three months ended Dec. 31, 2020, for a sales growth of 6.2% compared with Q4 2019. Earnings per share were -37¢, 12¢ […]
Philips appoints chief innovation and strategy officer
Royal Philips (NYSE:PHG) today said it has appointed Shez Partovi as chief innovation and strategy officer, effective July 1. Partovi replaces Jeroen Tas and will report directly to CEO Frans van Houten. He will also join Philips’s executive committee on March 22 to ensure a seamless transition. Tas will take on a part-time role at the […]
Silk Road Medical reports losses in Q4, sales up 13%
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that missed the consensus forecast on Wall Street, citing a second wave of COVID-19 in the last quarter of 2020. The Sunnyvale, Calif.-based company reported losses of -$16.8 million, or -49¢ per share, on sales of $21.1 million for the three months ended Dec. 31, 2020, for a […]
Hologic acquires molecular diagnostic company for $159M
Hologic today announced that it acquired molecular diagnostic company Diagenode for $159 million. Through the deal, Hologic will pay $159 million, subject to working capital and other customary closing adjustments. European Diagenode develops molecular diagnostic assays and epigenetic products. It has more than 30 real-time PCR tests that are CE-marked to detect bacteria, parasites and […]
Vascular Graft Solutions wins FDA approval for clampless proximal anastomosis
Vascular Graft Solutions today announced that it has received FDA approval for its Viola clampless anastomosis in coronary artery bypass grafting. The Viola device is designed to minimize aortic manipulation during on and off-pump coronary artery bypass grafting (CABG) to enable cardiac surgeons to perform protected, clean and dry proximal anastomosis without partial clamping the […]
Strata Skin Sciences names new president and CEO
Strata Skin Sciences today said that it has appointed Robert Moccia as president and CEO, effective immediately. Moccia replaces former president Dolev Rafaeli, who stepped down as president and CEO on Feb. 28. “We are delighted to welcome Bob to the Strata team. He is a leader in the field of dermatology, and we are […]
Fusion Robotics wins FDA clearance for 3D imaging robotic targeting system
Fusion Robotics this week announced that it has received FDA 510(k) clearance for its robotics system. The Fusion Robotics System is a 3D imaging compatible navigation and robotic targeting system for spinal surgery. “We appreciate the partnership developed with FDA to rigorously validate safety and accuracy. Next, we look forward to partnering with clinicians and […]
The top 7 medtech CEO quotes on COVID-19, one year later
The latest earnings season has provided insights into the future of medtech in the COVID-19 landscape and what certain sectors are seeing as vaccines start to roll out. Since the start of the pandemic, 113.1 million COVID-19 cases have been reported worldwide, according to Johns Hopkins University School of Medicine. The U.S. leads the world […]
FDA approves EndoClot hemostat for GI bleeding
EndoClot Plus this week announced that it has received FDA approval for its EndoClot Polysaccharide Hemostatic System (PHS). EndoClot PHS is a nonthermal, nontraumatic method for achieving hemostasis with GI bleeds and is designed to help gastroenterologists stop bleeding rapidly and reliably. The single-use device has a starch-based powder hemostat that is applied directly to […]
Elekta names permanent CFO
Elekta (STO:EKTA B) today said it has appointed Johan Adebäck as chief financial officer, effective immediately. Adebäck has served as the acting chief financial officer since June of last year. He was previously the group treasurer of the company since 2004, where he was responsible for treasury, taxes, customer financing, operations accounting and customer credit risk. […]
NuVasive acquires Simplify Medical in $150M deal
NuVasive (NSDQ:NUVA) yesterday announced that it has acquired Simplify Medical for $150 million. Through the deal, NuVasive made an upfront payment of $150 million at closing using cash on hand, subject to customary purchase price adjustments. The company agreed to make additional future payments contingent upon milestones related to regulatory approval and net sales. Simplify Medical […]